Skip to content

E A Carlini

4 papers in the library · 25 citations · publishing 1983-2006

Papers

Sort Most recent Most cited

A comparison of plants utilized in ritual healing by two Brazilian cultures: Quilombolas and Kraho Indians.

Journal of Psychoactive Drugs September 1, 2006 Eliana Rodrigues, E A Carlini

The present study deals with two ethnobotanical surveys carried out in two different segments of the Brazilian population: the first among the Krahô Indians living in Tocantins State, a Cerrado region, and the second one among the descendants of former black slaves, the Quilombolas, living in Mato Grosso State. Both populations use plants which may have effects on the central nervous system...

The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans.

Toxicon : official journal of the International Society on Toxinology September 15, 2004 E A Carlini

This review analyses the therapeutic usefulness of Delta(9)-tetrahydrocannabinol and its potential to induce adverse reactions on humans. During the last 30 years an enormous amount of research was carried out resulting in the disclosure of the cannabinoid system in Central Nervous System, with its CB(1) and CB(2) receptors, and the agonist anandamide. Under the clinical point of view,...

Plants and the central nervous system.

Pharmacology, biochemistry, and behavior June 2003 E A Carlini

This review article draws the attention to the many species of plants possessing activity on the central nervous system (CNS). In fact, they cover the whole spectrum of central activity such as psychoanaleptic, psycholeptic and psychodysleptic effects, and several of these plants are currently used in therapeutics to treat human ailments. Among the psychoanaleptic (stimulant) plants, those...

Serotonin receptor activation in rats previously deprived of REM sleep.

Pharmacology, biochemistry, and behavior April 1, 1983 R Santos, E A Carlini 25 citations

The effects of serotonin precursors (L-5-hydroxytryptophan and L-tryptophan, with or without MAO inhibitors) and of agonists (quipazine and 5-methoxy-N,N-dimethyltryptamine-MeO-DMT) were studied in 3 day REM-deprived or control rats, by recording the presence of the serotonin syndrome and the number of head shakes. The REM sleep-deprived rats showed a larger incidence of the serotonin syndrome...